Search Results - "Oechtering J"

Serum GFAP as a biomarker for progression in multiple sclerosis: assay comparison and a large reference database of healthy controls.

Authors: Willemse EAJ Sandgren S Benkert P et al.

Source: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2025 Dec 29; Vol. 64 (5), pp. 1046-1053. Date of Electronic Publication: 2025 Dec 29 (Print Publication: 2026).

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: Walter De Gruyter Country of Publication: Germany NLM ID: 9806306 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1437-4331 (Electronic) Linking ISSN: 14346621 NLM ISO Abbreviation: Clin Chem Lab Med Subsets: MEDLINE

Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity.

Authors: Sandgren S Maceski AM Benkert P et al.

Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2025 Nov; Vol. 31 (13), pp. 1531-1542. Date of Electronic Publication: 2025 Oct 14.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond.

Authors: Oechtering J Schaedelin SA Maleska Maceski A et al.

Corporate Authors: Oechtering J Schaedelin SA Maleska Maceski A et al.

Source: Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2026 May; Vol. 13 (3), pp. e200578. Date of Electronic Publication: 2026 Apr 23.

Publication Type: Journal Article

Journal Info: Publisher: Wolters Kluwer Health/Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101636388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2332-7812 (Electronic) Linking ISSN: 23327812 NLM ISO Abbreviation: Neurol Neuroimmunol Neuroinflamm Subsets: MEDLINE

Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis.

Authors: Furlan R Schaedelin S Frederiksen JL et al.

Source: Brain : a journal of neurology [Brain] 2026 Apr 07; Vol. 149 (4), pp. 1319-1331.

Publication Type: Journal Article; Observational Study; Multicenter Study

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0372537 Publication Model: Print Cited Medium: Internet ISSN: 1460-2156 (Electronic) Linking ISSN: 00068950 NLM ISO Abbreviation: Brain Subsets: MEDLINE

Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome.

Authors: Fissolo N Schaedelin S Villar LM et al.

Corporate Authors: Fissolo N Schaedelin S Villar LM et al.

Source: JAMA neurology [JAMA Neurol] 2025 Jul 01; Vol. 82 (7), pp. 722-733.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE

Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study.

Authors: Yaldizli Ö Benkert P Achtnichts L et al.

Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2025 Jul; Vol. 31 (8), pp. 932-943. Date of Electronic Publication: 2025 Apr 28.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

Serum Glial Fibrillary Acidic Protein and Retinal Neuronal Loss as Additive Prognostic Markers of Disability in Multiple Sclerosis.

Authors: Sellathurai S Schoenholzer K Burguet Villena F et al.

Source: Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2026 Jul; Vol. 13 (4), pp. e200571. Date of Electronic Publication: 2026 May 13.

Publication Type: Journal Article

Journal Info: Publisher: Wolters Kluwer Health/Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101636388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2332-7812 (Electronic) Linking ISSN: 23327812 NLM ISO Abbreviation: Neurol Neuroimmunol Neuroinflamm Subsets: MEDLINE

Serum GFAP and NfL augment a metabolomics-driven strategy for long-term prediction of multiple sclerosis progression.

Authors: Kacerova T Willemse E Oechtering J et al.

Source: Communications medicine [Commun Med (Lond)] 2026 Feb 25; Vol. 6 (1). Date of Electronic Publication: 2026 Feb 25.

Publication Type: Journal Article

Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) Subsets: PubMed not MEDLINE

GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.

Authors: Maceski AM Benkert P Einsiedler M et al.

Corporate Authors: Maceski AM Benkert P Einsiedler M et al.

Source: Brain : a journal of neurology [Brain] 2025 Nov 14. Date of Electronic Publication: 2025 Nov 14.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0372537 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2156 (Electronic) Linking ISSN: 00068950 NLM ISO Abbreviation: Brain Subsets: MEDLINE

Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response.

Authors: Einsiedler M Maceski AM Sandgren S et al.

Corporate Authors: Einsiedler M Maceski AM Sandgren S et al.

Source: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2025 Nov; Vol. 12 (11), pp. 2214-2225. Date of Electronic Publication: 2025 Aug 03.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2328-9503 (Electronic) Linking ISSN: 23289503 NLM ISO Abbreviation: Ann Clin Transl Neurol Subsets: MEDLINE

MultiSCRIPT-Cycle 1-a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trial.

Authors: Janiaud P Zecca C Salmen A et al.

Source: Trials [Trials] 2024 Sep 11; Vol. 25 (1), pp. 607. Date of Electronic Publication: 2024 Sep 11.

Publication Type: Journal Article; Clinical Trial Protocol

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

Unraveling Microstructural and Macrostructural Brain Age Dynamics in Multiple Sclerosis.

Authors: Chen X Lu PJ Ocampo-Pineda M et al.

Source: Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2025 Sep; Vol. 12 (5), pp. e200459. Date of Electronic Publication: 2025 Aug 19.

Publication Type: Journal Article

Journal Info: Publisher: Wolters Kluwer Health/Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101636388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2332-7812 (Electronic) Linking ISSN: 23327812 NLM ISO Abbreviation: Neurol Neuroimmunol Neuroinflamm Subsets: MEDLINE

Treatment Strategies and Disease Activity During Pregnancy and Postpartum: Real-World Data From the Swiss Multiple Sclerosis Cohort.

Authors: Einsiedler M Zecca C Hofer L et al.

Corporate Authors: Einsiedler M Zecca C Hofer L et al.

Source: Neurology. Clinical practice [Neurol Clin Pract] 2025 Aug; Vol. 15 (4), pp. e200499. Date of Electronic Publication: 2025 Jul 02.

Publication Type: Journal Article

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101577149 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2163-0402 (Print) Linking ISSN: 21630402 NLM ISO Abbreviation: Neurol Clin Pract Subsets: PubMed not MEDLINE

Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort.

Authors: Cagol A Schaedelin S Ocampo-Pineda M et al.

Corporate Authors: Cagol A Schaedelin S Ocampo-Pineda M et al.

Source: Journal of neurology [J Neurol] 2025 Jul 02; Vol. 272 (8), pp. 491. Date of Electronic Publication: 2025 Jul 02.

Publication Type: Journal Article; Observational Study; Multicenter Study; Comparative Study

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE

Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5.

Authors: Callegari I Oechtering J Schneider M et al.

Source: Brain : a journal of neurology [Brain] 2024 Mar 01; Vol. 147 (3), pp. 839-848.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0372537 Publication Model: Print Cited Medium: Internet ISSN: 1460-2156 (Electronic) Linking ISSN: 00068950 NLM ISO Abbreviation: Brain Subsets: MEDLINE

Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis.

Authors: Abdelhak A Benkert P Schaedelin S et al.

Corporate Authors: Abdelhak A Benkert P Schaedelin S et al.

Source: JAMA neurology [JAMA Neurol] 2023 Dec 01; Vol. 80 (12), pp. 1317-1325.

Publication Type: Observational Study; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE

Retinal neuronal loss and progression independent of relapse activity in multiple sclerosis.

Authors: Burguet Villena F Cerdá-Fuertes N Hofer L et al.

Source: Journal of neurology [J Neurol] 2025 Jun 10; Vol. 272 (7), pp. 454. Date of Electronic Publication: 2025 Jun 10.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE

Integrating TSPO-PET imaging with metabolomics for enhanced prognostic accuracy in multiple sclerosis.

Authors: Radford-Smith DE Yates AG Kacerova T et al.

Source: BMJ neurology open [BMJ Neurol Open] 2025 Apr 16; Vol. 7 (1), pp. e001026. Date of Electronic Publication: 2025 Apr 16 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: British Medical Association Country of Publication: England NLM ID: 101775450 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-6140 (Electronic) Linking ISSN: 26326140 NLM ISO Abbreviation: BMJ Neurol Open Subsets: PubMed not MEDLINE

Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis.

Authors: Oechtering J Schaedelin SA Stein K et al.

Corporate Authors: Oechtering J Schaedelin SA Stein K et al.

Source: Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2025 Mar; Vol. 12 (2), pp. e200361. Date of Electronic Publication: 2025 Jan 03.

Publication Type: Journal Article

Journal Info: Publisher: Wolters Kluwer Health/Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101636388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2332-7812 (Electronic) Linking ISSN: 23327812 NLM ISO Abbreviation: Neurol Neuroimmunol Neuroinflamm Subsets: MEDLINE

Modulator of VRAC Current 1 Is a Potential Target Antigen in Multiple Sclerosis.

Authors: Dahl JR Weier A Winter C et al.

Source: Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2025 Mar; Vol. 12 (2), pp. e200374. Date of Electronic Publication: 2025 Feb 11.

Publication Type: Journal Article

Journal Info: Publisher: Wolters Kluwer Health/Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101636388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2332-7812 (Electronic) Linking ISSN: 23327812 NLM ISO Abbreviation: Neurol Neuroimmunol Neuroinflamm Subsets: MEDLINE